Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ANI Pharmaceuticals Inc ANIP

ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company, which serves patients in need by developing, manufacturing and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset, Purified Cortrophin Gel... see more

NDAQ:ANIP - Post Discussion

ANI Pharmaceuticals Inc > Outperform Recommendation Issued On ANIP By Raymond James
View:
Post by whytestocks on Sep 18, 2024 11:31am

Outperform Recommendation Issued On ANIP By Raymond James

JUST IN: $ANIP Outperform Recommendation Issued On ANIP By Raymond James2024-09-18 10:30:03 ET Raymond James analyst issues OUTPERFORM recommendation for ANIP on September 18, 2024 09:14AM ET. The previous analyst recommendation was Outperform. ANIP was trading at $61.23 at issue of the analyst recommendation. The overall analyst consensus :...ANIP - Outperform Recommendation Issued On ANIP By Raymond James
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities